Document is current
Any future updates will be listed below
-
Authors
Tang, Yanyan
Zhao, Shijun
Zhou, Lina
Huang, Yao
Wang, Jianwei
Liang, Min
Wang, Fei
Zhu, Haohua
Qi, Linlin
Zhang, Li
Liu, Li
Hou, Donghui
Xu, Zhijian
Zhang, Kai
Tang, Wei
Wu, Ning
-
Funding
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021A25)
the National Key R&D Program of China (2017YFC1308700)
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 10 October 2024
First Online: 28 October 2024
Declarations
:
: This study was approved by the Ethics Committee of the National Cancer Center of China (NCC)/Cancer Hospital of the Chinese Academy of Medical Sciences (Application ID:14–115/905). The approval allowed participants or their institutions to pay for the lung cancer screening. Participants provided informed consent, allowing their institutions to financially support the LCS.
: Not applicable.
: The authors declare no competing interests.
